Skip to main content
Premium Trial:

Request an Annual Quote

U. of Liverpool Awarded $33.5M to Build Personalized Medicine Incubator Space

NEW YORK (GenomeWeb) – The University of Liverpool said on Wednesday that it has been awarded about £20.5 million ($33.5 million) to build an incubator space for small and medium-sized businesses operating in the personalized medicine arena.

The Liverpool Bio Innovation Hub will encompass more than 6,000 square meters and will include laboratory and office space, allowing commercial access to biobank technologies and genomic, proteomic, and metabolomic equipment.

Munir Pirmohamed, head of the Wolfson Centre for Personalised Medicine, said in a statement that the Bio Hub will facilitate collaboration between the university, the UK's National Health Service partners, and industry "to ensure that medical research is translated effectively into outputs that will benefit patients. It provides industry with access to expertise, biosamples, and high-end equipment, as well as opportunities for researchers to work with commercial enterprises."

The space is anticipated to open next year.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.